Abstract
Hypophosphatasia is an inherited metabolic bone disease from deficient activity of tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). A condition which was first described in 1948 by Dr. John C Rathbun, hypophosphatasia affects approximately 500–600 known individuals in the United States. It clinically presents in different forms of severity ranging from nonspecific symptoms in adults to very severe perinatal form including death in utero. However, a common feature of hypophosphatasia across all age groups is reduced serum alkaline phosphatase leading to defective bone mineralization. Management involves medical treatment, surgical repair, and enzyme replacement therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Whyte MP. Hypophosphatasia – aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233–46.
Mornet E. Hypophosphatasia. Metabolism. 2018;82:142–55.
Shapiro JR, Lewiecki EM. Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res. 2017;32(10):1977–80.
Millan JL, Whyte MP. Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int. 2016;98(4):398–416.
Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int. 2015;26(12):2743–57.
Whyte MP, Zhang F, Wenkert D, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015;75:229–39.
Kishnani PS, Rush ET, Arundel P, et al. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1–2):4–17.
Mori M, Dearmey SL, Weber TJ, Kishnani PS. Case series: odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? – Call for a long-term follow-up of premature loss of primary teeth. Bone Rep. 2016;5:228–32.
Schmidt T, Mussawy H, Rolvien T, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653–62.
Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab. 2007;92(4):1203–8.
Camacho PM, Mazhari AM, Wilczynski C, Kadanoff R, Mumm S, Whyte MP. Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature. Endocr Pract. 2016;22(8):941–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arceo-Mendoza, R.M., Bacal, A.M., Camacho, P.M. (2019). Hypophosphatasia. In: Camacho, P. (eds) Metabolic Bone Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-03694-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-03694-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03693-5
Online ISBN: 978-3-030-03694-2
eBook Packages: MedicineMedicine (R0)